secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0001104659-24-078557
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Animal Health enters $960M credit facility with Rabobank; delayed draw for Zoetis acquisition
--------------------------------------------------------------------------------

- Term A-1 loans total $351M (initial $162M + delayed $189M); Term A-2 loans total $299M.
- Revolving credit commitment of $310M; Term A-1 and Revolver mature July 2029, Term A-2 July 2031.
- Proceeds used to refinance existing debt, pay fees, and fund Zoetis Acquisition via delayed draw facilities.
- Interest rates based on Net Leverage Ratio; commitment fees 0.20%-0.35% on undrawn commitments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000110465924078557/0001104659-24-078557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000110465924078557/tm2419097d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-078557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer